Stockreport

Australian biopharma company Immuron's stock is up 1,000% on new-drug news [MarketWatch]

Immuron Limited - American Depositary Shares  (IMRN) 
US:NASDAQ Investor Relations: immuron.com/investor-centre/business-overview
PDF Australian biopharma company Immuron's stock is up 1,000% on new-drug news [Read more]